Donor‐Derived Cell‐Free as a Marker for the Efficacy of Daratumumab in Patients With Antibody‐Mediated Rejection Post‐Heart Transplantation: A Case Series
Publication
, Journal Article
Konduri, A; Flynn, KE; Huebschman, A; Crandall, B; Sinicropi, N; Giacobbe, B; Zamberlan, M; Najor, M; Cusick, M; Lim, HM; McCormick, AD ...
Published in: Pediatric Transplantation
September 2025
Duke Scholars
Published In
Pediatric Transplantation
DOI
EISSN
1399-3046
ISSN
1397-3142
Publication Date
September 2025
Volume
29
Issue
6
Publisher
Wiley
Related Subject Headings
- Surgery
- 3213 Paediatrics
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
Citation
APA
Chicago
ICMJE
MLA
NLM
Konduri, A., Flynn, K. E., Huebschman, A., Crandall, B., Sinicropi, N., Giacobbe, B., … Peng, D. M. (2025). Donor‐Derived Cell‐Free
DNA
as a Marker for the Efficacy of Daratumumab in Patients With Antibody‐Mediated Rejection Post‐Heart Transplantation: A Case Series. Pediatric Transplantation, 29(6). https://doi.org/10.1111/petr.70168
Konduri, Anusha, Kathryn E. Flynn, Ashley Huebschman, Bronwyn Crandall, Natalie Sinicropi, Bethany Giacobbe, Mary Zamberlan, et al. “Donor‐Derived Cell‐Free
DNA
as a Marker for the Efficacy of Daratumumab in Patients With Antibody‐Mediated Rejection Post‐Heart Transplantation: A Case Series.” Pediatric Transplantation 29, no. 6 (September 2025). https://doi.org/10.1111/petr.70168.
Konduri A, Flynn KE, Huebschman A, Crandall B, Sinicropi N, Giacobbe B, et al. Donor‐Derived Cell‐Free
DNA
as a Marker for the Efficacy of Daratumumab in Patients With Antibody‐Mediated Rejection Post‐Heart Transplantation: A Case Series. Pediatric Transplantation. 2025 Sep;29(6).
Konduri, Anusha, et al. “Donor‐Derived Cell‐Free
DNA
as a Marker for the Efficacy of Daratumumab in Patients With Antibody‐Mediated Rejection Post‐Heart Transplantation: A Case Series.” Pediatric Transplantation, vol. 29, no. 6, Wiley, Sept. 2025. Crossref, doi:10.1111/petr.70168.
Konduri A, Flynn KE, Huebschman A, Crandall B, Sinicropi N, Giacobbe B, Zamberlan M, Najor M, Cusick M, Lim HM, McCormick AD, Schumacher KR, Peng DM. Donor‐Derived Cell‐Free
DNA
as a Marker for the Efficacy of Daratumumab in Patients With Antibody‐Mediated Rejection Post‐Heart Transplantation: A Case Series. Pediatric Transplantation. Wiley; 2025 Sep;29(6).
Published In
Pediatric Transplantation
DOI
EISSN
1399-3046
ISSN
1397-3142
Publication Date
September 2025
Volume
29
Issue
6
Publisher
Wiley
Related Subject Headings
- Surgery
- 3213 Paediatrics
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine